Skip to content

H.R. 9699 · 119th Congress (2025–2027)

Drug Deal Disclosure Act

To require the Department of Health and Human Services to release documents, communications, and other information relating to most favored nation pricing agreements and other private or confidential drug pricing deals struck with manufacturers, and for other purposes.

CRS summary not yet available.

Referred to committee

Latest actionReferred to committee

This bill’s path

This is H.R. 9699’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed House

  3. Passed Senate

  4. Sent to President

  5. Signed into law

Sponsor
Rep. Judy Chu (D-CA-28)
Cosponsors
24 cosponsors

23 original · 1 later

24 D

  1. Rep. Donald S. Beyer, Jr. (D-VA-8)· Original · Jul 15, 2026
  2. Rep. Kathy Castor (D-FL-14)· Original · Jul 15, 2026
  3. Rep. Yvette D. Clarke (D-NY-9)· Original · Jul 15, 2026
  4. Rep. André Carson (D-IN-7)· Original · Jul 15, 2026
  5. Rep. Lloyd Doggett (D-TX-37)· Original · Jul 15, 2026
  6. Rep. Suzan K. DelBene (D-WA-1)· Original · Jul 15, 2026
  7. Rep. Maxine Dexter (D-OR-3)· Original · Jul 15, 2026
  8. Rep. Dwight Evans (D-PA-3)· Original · Jul 15, 2026
  9. Rep. Maggie Goodlander (D-NH-2)· Original · Jul 15, 2026
  10. Rep. Summer L. Lee (D-PA-12)· Original · Jul 15, 2026
  11. Rep. Kweisi Mfume (D-MD-7)· Original · Jul 15, 2026
  12. Rep. Betty McCollum (D-MN-4)· Original · Jul 15, 2026
  13. Rep. Gwen Moore (D-WI-4)· Original · Jul 15, 2026
  14. Rep. Doris O. Matsui (D-CA-7)· Original · Jul 15, 2026
  15. Del. Eleanor Holmes Norton (D-DC)· Original · Jul 15, 2026
  16. Rep. Jimmy Panetta (D-CA-19)· Original · Jul 15, 2026
  17. Rep. Chris Pappas (D-NH-1)· Original · Jul 15, 2026
  18. Rep. Deborah K. Ross (D-NC-2)· Original · Jul 15, 2026
  19. Rep. Janice D. Schakowsky (D-IL-9)· Original · Jul 15, 2026
  20. Rep. Bradley Scott Schneider (D-IL-10)· Original · Jul 15, 2026
  21. Rep. Mark Takano (D-CA-39)· Original · Jul 15, 2026
  22. Rep. Rashida Tlaib (D-MI-12)· Original · Jul 15, 2026
  23. Rep. Nikema Williams (D-GA-5)· Original · Jul 15, 2026
  24. Rep. Paul Tonko (D-NY-20)· Later · Jul 16, 2026
Policy area
Health

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in House

    Document: Introduced in House

    Sources
  2. Latest

    Referred to committee

    Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Sources

Committees

  1. HouseBudgetReferred Jul 15, 2026
  2. HouseEnergy and CommerceReferred Jul 15, 2026
  3. HouseWays and MeansReferred Jul 15, 2026

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in House
Titles (2)
  1. To require the Department of Health and Human Services to release documents, communications, and other information relating to most favored nation pricing agreements and other private or confidential drug pricing deals struck with manufacturers, and for other purposes.

    Official title · Introduced in House

  2. Drug Deal Disclosure Act

    Display title, Short title · Introduced in House